Cryptos: 32,529 Exchanges: 354 Market Cap: $3,536.41B 24h Vol: $79.59B Dominance: BTC 53.2% ETH 11.8% ETH Gas:  3 Gwei
Seclect Currency

Fiat currencies

    Crypto Currencies

      No results for ""

      We couldn't find anything matching your search.Try again with a different term.

      Dylibso's Logo

      Dylibso - Seed

      Overview Investors Founders Company Profile / Project Introduction

      Overview

      Funding Date

      March 24, 2023

      Financing amount

      $6.6M

      Valuation

      --

      Category

      Infrastructure

      Subcategory

      --

      About Dylibso - Seed

      Dylibso, a Barcelona, Spain-based WebAssembly (WASM) company, raised $6.6M in funding. The round was led by Felicis with participation from pre-seed investors boldstart ventures, Pebblebed and Crew Capital. The company intends to use the funds to expand operations and its business reach.

      Investors

      InvestorsTypeLocationYear Founded#Portfolio CompaniesEmail AddressSocials
      Fund United States of America 2006 4 --
      Fund United States of America 2010 10 [email protected]
      Corporate United States of America -- 1 [email protected]
      Fund United States of America -- 3 --

      Founders & Team

      Steve Manuel's Logo

      Steve Manuel

      Zach Shipko's Logo

      Zach Shipko

      Benjamin Eckel's Logo

      Benjamin Eckel

      Company Profile / Project Introduction

      Dylibso is the company behind the open source Universal Plug-in System, Extism, and announced the general availability of its first product, Modsurfer, the system of record for WASM. Modsurfer provides dev and ops teams with a system of record plus diagnostics applications to track, investigate, search and validate WebAssembly modules, allowing developers to gain visibility and analytics into their WebAssembly binaries. Additionally, Modsurfer brings maturity to WebAssembly in four core areas – serverless, browser, plug-ins and Web3/blockchain.

      View More
      *Fundraising Announcement: Click here